Moreover, ac4C-RIP assays indicated that p21 mRNA could undergo ac4C modification (Fig. 7E), and NAT10 knockdown decreased the ac4C modification of p21 mRNA in bladder cancer cells (Fig. 7F and Fig. S5A). The gene discussed is NAT10; the disease is urinary bladder cancer.